And nothing reinforced such staying power more than the unveiling of PSA’s Most Expensive Perfect 10s, which notes the ...
MedPage Today on MSN
Men Unlikely to Benefit Are Getting PSA Testing Anyhow
Contrary to recommendations regarding age and PSA screening, over the course of nearly two decades the highest PSA testing ...
News Medical on MSN
Prostate testing may not target those most likely to benefit, warn experts
Current prostate specific antigen (PSA) testing "may not effectively target testing to those most likely to benefit, raising ...
Patients with D2T-PsA can be stratified into inflammatory and noninflammatory phenotypes, with the former linked to higher sonographic activity.
1. Historic Leap: BYD's Market Share in Europe Surpasses Tesla, Transforming the New Energy Landscape ...
Explore PFXF ETF for a 7% yield with industry diversification. Compare its returns and risks to top competitors.
Most children with JPsA show improved disease activity over the first 2 years of treatment, despite requiring early systemic therapy.
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the first patient has been dosed in Part 3 of the Company’s Phase 1 clinical trial evaluating VIR-5500 in combination with androgen receptor ...
Zacks Investment Research on MSN
OUT vs. PSA: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the REIT and Equity Trust - Other sector have probably already heard of Outfront Media (OUT) and Public Storage (PSA). But which of these two companies is the best ...
Icotrokinra met the primary endpoint of clinical response at all three doses, with 36.5% of patients treated achieving endoscopic improvement and 30.2% achieving clinical remission at the highest dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results